主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IPSC
#3009
Century Therapeutics, Inc. Common Stock
2.3
2
+6.42%
版块:
基础:
利润货币:
日范围
年范围
日变化
+6.42%
每月变动
-13.43%
6个月变化
+346.15%
年变化
+256.92%
前一天收盘价
2.1
8
Open
2.3
2
Bid
Ask
Low
2.3
2
High
2.3
2
交易量
15
市场
股票
医疗保健
IPSC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
新闻
TD Cowen首次覆盖Century Therapeutics股票,评级为买入
TD Cowen initiates Century Therapeutics stock rating at Buy
Clear Street重申Century Therapeutics股票买入评级,目标价6.60美元
Oracle, Palantir among market cap stock movers on Monday
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Clear Street下调世纪治疗(Century Therapeutics)股价目标至6.60美元
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Century Therapeutics secures $135 million in private placement
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors